SAB Biotherapeutics Stock Performance
as on November 7, 2026 at 2:16 pm IST
Day's Low
Day's High
$2.92$3.05
3.63%
Downside
0.66%
Upside
52 Week's Low
52 Week's High
$2.44$5.1519.47%
Downside
69.97%
Upside
SAB Biotherapeutics share price movements today
- Previous Close
- $2.94
- Open
- $3.00
- Volume
- 406.7K
- Market Cap
- $267.5M
- Day's Low - High
- $2.92 - $3.05
- 52 Week Low - High
- $2.44 - $5.15
SAB Biotherapeutics Historical Returns
- 1 Month Return
- + 5.21 %
- 3 Month Return
- -22.31 %
- 1 Year Return
- -5.31 %
- 3 Year Return
- -69.39 %
- 5 Year Return
- -96.37 %
SAB Biotherapeutics Stock Fundamentals & Key Indicators
Check SAB Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$267.5M
EPS (TTM)
-0.9298
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.60%
PE Ratio (TTM)
-3.26
Industry PE ratio
-7.71
PEG Ratio
0.02
EBITDA
-81.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-40.04%
SAB Biotherapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of SAB Biotherapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $267.5M | -96.37% | -3.26 | 0.00% | 0.00% | |
| Neutral | $96.4B | 7.26% | -35.95 | 28.00% | 0.00% | |
| StrongBuy | $44.1B | NA | 27.92 | 87.82% | 0.00% | |
| StrongBuy | $137.5B | 183.69% | 34.94 | 85.57% | 0.00% | |
| Buy | $96.3B | 47.88% | 19.26 | 85.77% | 0.41% |
Stock Returns calculator for SAB Biotherapeutics Stock including INR - Dollar returns
The SAB Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
SAB Biotherapeutics investment value today
Current value as on today
₹1,00,241
Returns
₹241
(+0.24%)
Returns from SAB Biotherapeutics Stock
Dollar Impact
₹5,554 (+5.55%)
Analyst Recommendation on SAB Biotherapeutics Stock
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for SAB Biotherapeutics. Average target price of $11.64
SAB Biotherapeutics Share Price Target
Get share price movements and forecasts by analysts on SAB Biotherapeutics.
What analysts predicted
73.97%UPSIDE
Target Price
$11.64
Current Price
$3.03
Analyzed by
8 Analysts
Target
$11.64
SAB Biotherapeutics target price $11.64, a slight upside of 73.97% compared to current price of $3.03. According to 8 analysts rating.
Indian Investors' Interest in SAB Biotherapeutics Stock
Search interest for SAB Biotherapeutics Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
SAB Biotherapeutics Quarterly Profit & Loss
All numbers in Millions USD
SAB Biotherapeutics Annual Profit & Loss
All numbers in Millions USD
SAB Biotherapeutics Quarterly Cash Flow
All numbers in Millions USD
SAB Biotherapeutics Annual Cash Flow
All numbers in Millions USD
SAB Biotherapeutics News & Key Events
Today's Timeline - 13 October
Tue, 06:10 PM
-SAB Biotherapeutics receives FDA Fast Track designation for SAB-142, an immunotherapy for new-onset Stage 3 type 1 diabetes.
Insights on SAB Biotherapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 941.1%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 265.7% return, outperforming this stock by 334.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 4 quarters, 45.44M → -22.49M (in $), with an average decrease of 56.1% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, SABS stock has moved down by -8.2%
About SAB Biotherapeutics
| Organisation | SAB Biotherapeutics |
| Headquarters | 777 W 41st St., Miami Beach, FL, 33140, US |
| Industry | Biotechnology |
| CEO | Samuel J. Reich |
Key Management of SAB Biotherapeutics
Name | Title |
|---|---|
Ms. Lucy To | Executive VP & CFO |
Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer |
Dr. Carlos N. Carillo M.Sc., Ph.D. | Senior Vice President of Regulatory Affairs |
Ms. Angie Parizek | Senior Vice President of Clinical Operations |
Mr. Samuel J. Reich | CEO & Director |
Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director |
Ms. Hua Wu Ph.D. | Senior Vice President of Product Development |
Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO |
Ms. Catherine DeRose | Vice President of Human Resources |
FAQs
What is SAB Biotherapeutics share price today?
SAB Biotherapeutics share price today is $3.03 as on at the close of the market. SAB Biotherapeutics share today touched a day high of $3.05 and a low of $2.92.
What is the 52 week high and 52 week low for SAB Biotherapeutics share?
SAB Biotherapeutics share touched a 52 week high of $5.15 on and a 52 week low of $2.44 on . SAB Biotherapeutics stock price today i.e. is closed at $3.03,which is 41.17% down from its 52 week high and 24.18% up from its 52 week low.
What is SAB Biotherapeutics's market capitalisation today?
SAB Biotherapeutics market capitalisation is $0.00T as on .
How to invest in SAB Biotherapeutics Stock (SABS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for SAB Biotherapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy SAB Biotherapeutics Stock (SABS) from India?
Indian investors can start investing in SAB Biotherapeutics (SABS) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in SAB Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on SAB Biotherapeutics share’s latest price of $3.03 as on November 7, 2026 at 8:46 am IST, you will get 3.3003 shares of SAB Biotherapeutics. Learn more about
fractional shares .
What are the returns that SAB Biotherapeutics has given to Indian investors in the last 5 years?
SAB Biotherapeutics stock has given -96.37% share price returns and 27.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?